Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F de Groot

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Journal of Neuro-Oncology|October 24, 2019
Treatment strategies for glioblastoma in older patients: age is just a numberMichael Youssef, Ethan B Ludmir, Jacob J Mandel, et al.
Journal of the Neurological Sciences|June 19, 2021
IDH mutation status and the development of venous thromboembolism in astrocytoma patientsJacob J Mandel, Michael Youssef, Shlomit Yust-Katz, et al.
Neuro-Oncology|October 11, 2017
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastomaJacob J Mandel, Shlomit Yust-Katz, Akash J Patel, et al.
Neuro-Oncology|December 6, 2013
Clinical and prognostic features of adult patients with gangliogliomasShlomit Yust-Katz, Mark Daniel Anderson, Diane Liu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 6, 2022
Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for RadiologistsPatricia M de Groot, Octavio Arevalo, Komal Shah, et al.
Neuro-Oncology|November 4, 2019
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implicationsJun Wei, Peiwen Chen, Pravesh Gupta, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuro-Oncology|August 19, 2008
VEGF Trap induces antiglioma effect at different stages of diseaseCandelaria Gomez-Manzano, Jocelyn Holash, Juan Fueyo, et al.
Neuro-Oncology Advances|December 22, 2023
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastomaSabbir Khan, Emmanuel Martinez-Ledesma, Jianwen Dong, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Journal of Neuro-Oncology|October 24, 2019
Treatment strategies for glioblastoma in older patients: age is just a numberMichael Youssef, Ethan B Ludmir, Jacob J Mandel, et al.
Journal of the Neurological Sciences|June 19, 2021
IDH mutation status and the development of venous thromboembolism in astrocytoma patientsJacob J Mandel, Michael Youssef, Shlomit Yust-Katz, et al.
Neuro-Oncology|October 11, 2017
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastomaJacob J Mandel, Shlomit Yust-Katz, Akash J Patel, et al.
Neuro-Oncology|December 6, 2013
Clinical and prognostic features of adult patients with gangliogliomasShlomit Yust-Katz, Mark Daniel Anderson, Diane Liu, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 6, 2022
Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for RadiologistsPatricia M de Groot, Octavio Arevalo, Komal Shah, et al.
Neuro-Oncology|November 4, 2019
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implicationsJun Wei, Peiwen Chen, Pravesh Gupta, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuro-Oncology|August 19, 2008
VEGF Trap induces antiglioma effect at different stages of diseaseCandelaria Gomez-Manzano, Jocelyn Holash, Juan Fueyo, et al.
Neuro-Oncology Advances|December 22, 2023
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastomaSabbir Khan, Emmanuel Martinez-Ledesma, Jianwen Dong, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Pageof 13